MODIFICATION TO SMITH & NEPHEW INTRAMEDULLARY HIP SCREW

K040656 · Smith & Nephew, Inc. · HWC · May 25, 2004 · Orthopedic

Device Facts

Record IDK040656
Device NameMODIFICATION TO SMITH & NEPHEW INTRAMEDULLARY HIP SCREW
ApplicantSmith & Nephew, Inc.
Product CodeHWC · Orthopedic
Decision DateMay 25, 2004
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3040
Device ClassClass 2
AttributesTherapeutic

Intended Use

Intramedullary Hip Screws are indicated for intracapsular fractures of the femoral neck; trochanteric or subtrochanteric fractures; osteotomies for patients with diseases or deformities of the hip; hip arthrodesis; supracondylar fractures and distal femoral fractures using a supracondylar plate; ipsilateral femoral shaft/neck fractures; intertrochanteric fractures; femoral neck fractures; subcapital fractures; comminuted neck and shaft fractures; femur reconstruction following tumor resection; leg length discrepancies secondary to femoral inequality; and prophylactic nailing of impending pathologic fractures. Smith & Nephew, Inc. Intramedullary Hip Screws are for single use only.

Device Story

Intramedullary Hip Screw is a metallic bone fixation device; used for stabilization of femoral fractures and reconstruction. Device implanted by surgeons in clinical/OR settings; provides mechanical support to bone segments during healing. Operates via internal fixation; designed to withstand in vivo loading. Single-use device; provides structural stability to facilitate bone union and patient mobility. Benefits include fracture stabilization and correction of femoral deformities.

Clinical Evidence

Bench testing only; no clinical data provided. Mechanical test data indicates the device is equivalent to predicate devices and capable of withstanding expected in vivo loading.

Technological Characteristics

Metallic bone fixation appliance; single/multiple component design. Materials and design features are consistent with legally marketed predicate devices for orthopedic fixation.

Indications for Use

Indicated for patients with femoral fractures (intracapsular, trochanteric, subtrochanteric, supracondylar, distal, shaft/neck, intertrochanteric, subcapital, comminuted), hip deformities/diseases requiring osteotomy or arthrodesis, femur reconstruction post-tumor resection, leg length discrepancies, and prophylactic nailing for impending pathologic fractures.

Regulatory Classification

Identification

A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ **MAY 25 2004** K04 0656 Page 1 of 1 ## Smith & Nephew, Inc. Summary of Safety and Effectiveness Intramedullary Hip Screw #### Date of Summary: March 11, 2004 Contact Person and Address Janet Akil Director, Regulatory Affairs Smith & Nephew, Inc. Orthopaedic Division 1450 East Brooks Road Memphis, TN 38116 (901) 399-5153 Name of Device: Intramedullary Hip Screw Common Name: Intramedullary Hip Screw Nails and Accessories #### Device Classification Name 21 CFR 888.3030 Single/multiple component metallic bone fixation appliances and accessories - Class II ### Indications for Use Intramedullary Hip Screws are indicated for intracapsular fractures of the femoral neck; trochanteric or subtrochanteric fractures; osteotomies for patients with diseases or deformities of the hip; hip arthrodesis; supracondylar fractures and distal femoral fractures using a supracondylar plate; ipsilateral femoral shaft/neck fractures; intertrochanteric fractures; femoral neck fractures; subcapital fractures; comminuted neck and shaft fractures; femur reconstruction following turnor resection; leg length discrepancies secondary to femoral inequality; and prophylactic nailing of impending pathologic fractures. Smith & Nephew, Inc. Intramedullary Hip Screws are for single use only. #### Mechanical and Clinical Data A review of the mechanical test data indicated that the Intramedullary Hip Screw is equivalent to predicate devices currently used clinically and is capable of withstanding expected in vivo loading without failure. #### Substantial Equivalence Information The substantial equivalence of the Intramedullary Hip Screw is based on its similarities in indications for use, design features, operational principles, and material composition to the following predicate devices - Smith & Nephew's Intramedullary Hip Screw (K954712), Titanium Nail System (K981529), Trauma Internal Fixation System (K993289), Intramedullary Nail System (K983942) and TriGen InterTAN (K040212). {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS). The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three wavy lines, which represent the department's mission to promote the health and well-being of all Americans. #### Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 MAY 2 5 2004 Ms. Janet Akil Director, Regulatory Affairs Smith & Nephew, Inc. Orthopaedic Division 1450 East Brooks Road Memphis, Tennessee 38116 Re: K040656 Trade/Device Name: Intramedullary Hip Screw Regulation Number: 21 CFR 888.3030 and 21 CFR 888.3040 Regulation Names: Single/multiple component metallic bone fixation appliances and accessories, and Smooth or threaded metallic bone fixation fastener Regulatory Class: II Product Codes: KTT and HWC Dated: March 11, 2004 Received: March 12, 2004 Dear Ms. Akil: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice rcquirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {2}------------------------------------------------ Page 2 - Ms. Janet Akil This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Mark A. Wilkerson Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ # Indications for Use ## 510(k) Number (if known): K040656 Device Name: Intramedullary Hip Screw Intramedullary Hip Screws are indicated for intracapsular Indications For Use: fractures of the femoral neck; trochanteric or subtrochanteric fractures; osteotomies for patients with diseases or deformities of the hip; hip arthrodesis; supracondylar fractures and distal femoral fractures using a supracondylar plate; ipsilateral femoral shaft/neck fractures; intertrochanteric fractures; femoral neck fractures; subcapital fractures; comminuted neck and shaft fractures; femur reconstruction following tumor resection; leg length discrepancies secondary to femoral inequality; and prophylactic nailing of impending pathologic fractures. Smith & Nephew, Inc. Intramedullary Hip Screws are for single use only. Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Mark H. Millhess (Division Digand Neurological Devices Page 1 of 1 510(k) Number K040656
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...